Cargando…
Occurrence of CYP2B6 516G>T polymorphism in patients with ARV‐associated hepatotoxicity
BACKGROUND: Hepatic enzyme cytochrome P450 2B6 (CYP2B6) plays a role in the metabolism of efavirenz drugs. CYP2B6 516G>T variation showed an implication for HIV treatment. METHODS: CYP2B6 516G>T polymorphism was genotyped in a total 165 HIV patients that include 34 with and 131 without hepatot...
Autores principales: | Singh, HariOm, Lata, Sonam, Dhole, T. N., Gangakhedkar, Raman R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465650/ https://www.ncbi.nlm.nih.gov/pubmed/30864294 http://dx.doi.org/10.1002/mgg3.598 |
Ejemplares similares
-
Prevalence of ABCC3‐1767G/A polymorphism among patients with antiretroviral‐associated hepatotoxicity
por: Singh, HariOm, et al.
Publicado: (2020) -
IL-1RN and IL-1β Polymorphism and ARV-Associated Hepatotoxicity
por: Singh, HariOm, et al.
Publicado: (2018) -
Polymorphisms in miRNAs Gene (146a, 149, 196a) and Susceptibility to ARV-associated Hepatotoxicity
por: Singh, Hari Om, et al.
Publicado: (2019) -
Distribution of CYP2B6 516G/T pharmacogenetically important polymorphism in the Ukrainian population
por: Filiptsova, Olga, et al.
Publicado: (2018) -
The G(516)T CYP2B6 Germline Polymorphism Affects the Risk of Acute Myeloid Leukemia and Is Associated with Specific Chromosomal Abnormalities
por: Daraki, Aggeliki, et al.
Publicado: (2014)